Compounds > fluorodopa f 18
Page last updated: 2024-08-24

fluorodopa f 18 and Syndrome

fluorodopa f 18 has been researched along with Syndrome in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (50.00)18.2507
2000's1 (16.67)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adam, MJ; Levine, DS; Metzger, DL; Nadel, HR; Oviedo, A; Skarsgard, E1
Bartsch, O; Fottner, C; Helisch, A; Lackner, KJ; Mann, WJ; Miederer, M; Musholt, TJ; Papaspyrou, K; Rossmann, H; Schreckenberger, M; Weber, MM1
Brink, I; Neumann, HP; Schaefer, O; Walz, M1
Chaly, T; Dhawan, V; Eidelberg, D; Fahn, S; Giladi, N; Ishikawa, T; Przedborski, S; Spetsieris, P; Takikawa, S1
Calne, DB; Langston, JW; Schulzer, M; Snow, BJ; Tetrud, JW; Vingerhoets, FJ1
Brooks, DJ; Lees, AJ; Turjanski, N1

Other Studies

6 other study(ies) available for fluorodopa f 18 and Syndrome

ArticleYear
Novel use of F-DOPA PET/CT imaging in a child with paraganglioma/pheochromocytoma syndrome.
    Pediatric radiology, 2011, Volume: 41, Issue:10

    Topics: Adolescent; Adrenal Gland Neoplasms; Dihydroxyphenylalanine; Female; Humans; Kidney Neoplasms; Multimodal Imaging; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Syndrome; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Ultrasonography, Interventional; Whole Body Imaging

2011
High incidence of extraadrenal paraganglioma in families with SDHx syndromes detected by functional imaging with [18F]fluorodihydroxyphenylalanine PET.
    European journal of nuclear medicine and molecular imaging, 2013, Volume: 40, Issue:6

    Topics: Adolescent; Adult; Child; Dihydroxyphenylalanine; False Negative Reactions; Female; Germ-Line Mutation; Humans; Incidence; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Mutation; Paraganglioma, Extra-Adrenal; Positron-Emission Tomography; Sensitivity and Specificity; Succinate Dehydrogenase; Syndrome; Young Adult

2013
Fluorine-18 DOPA PET imaging of paraganglioma syndrome.
    Clinical nuclear medicine, 2006, Volume: 31, Issue:1

    Topics: Abdominal Neoplasms; Child; Dihydroxyphenylalanine; Head and Neck Neoplasms; Humans; Male; Paraganglioma; Positron-Emission Tomography; Radiopharmaceuticals; Succinate Dehydrogenase; Syndrome

2006
Metabolic topography of the hemiparkinsonism-hemiatrophy syndrome.
    Neurology, 1994, Volume: 44, Issue:9

    Topics: Adult; Atrophy; Brain; Deoxyglucose; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Parkinson Disease; Syndrome; Tomography, Emission-Computed

1994
Positron emission tomographic evidence for progression of human MPTP-induced dopaminergic lesions.
    Annals of neurology, 1994, Volume: 36, Issue:5

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adult; Aged; Aged, 80 and over; Corpus Striatum; Dihydroxyphenylalanine; Disease Progression; Dopamine; Female; Humans; Male; Middle Aged; Parkinson Disease, Secondary; Substantia Nigra; Syndrome; Tomography, Emission-Computed

1994
Striatal dopaminergic function in restless legs syndrome: 18F-dopa and 11C-raclopride PET studies.
    Neurology, 1999, Mar-23, Volume: 52, Issue:5

    Topics: Aged; Carbon Radioisotopes; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Female; Humans; Kinetics; Male; Middle Aged; Raclopride; Restless Legs Syndrome; Salicylamides; Syndrome; Tomography, Emission-Computed

1999